Evidence map›Paper›PMID 28712387›Full record

ArticleBMB reports2017

SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.

Heegyum Moon, Sunghee Cho, Tiing Jen Loh, Ha Na Jang, Yongchao Liu, Namjeong Choi, Jagyeong Oh, Jiyeon Ha, Jianhua Zhou, Sungchan Cho and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMB reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. RNA Splicing as a Therapeutic Target in Cancer.Annual review of pharmacology and toxicology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Splice site mPeerJ · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Splicing factor SRSF2-centric gene regulation.International journal of biological sciences · 2021
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Heegyum MoonSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Sunghee ChoSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Tiing Jen LohSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Ha Na JangSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Yongchao LiuSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Namjeong ChoiSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Jagyeong OhSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Jiyeon HaSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Jianhua ZhouJiangSu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226019, China.
Sungchan ChoBio-Therapeutics Research Institute, Korea Research Institute of Bioscience and Biotechnology, Chungbuk 28116, Korea.
Dong-Eun KimDepartment of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea.
Michael B YeDivision of Liberal Arts and Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Xuexiu ZhengSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Haihong ShenSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea.
Gwangju Institute of Science and Technology · KRKonkuk University · KRNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SRSF2, a Serine-Arginine rich (SR) protein, is a splicing activator that mediates exon inclusion and exclusion events equally well. Here we show SRSF2 directly suppresses intron splicing to suppress cassette exon inclusion in SMN premRNA. Through a serial mutagenesis, we demonstrate that a 10 nt RNA sequence surrounding the branch-point (BP), is important for SRSF2-mediated inhibition of cassette exon inclusion through directly interacting with SRSF2. We conclude that SRSF2 inhibits intron splicing to promote exon exclusion. [BMB Reports 2017; 50(8): 423-428].

Indexed as

ExonsIntronsAlternative SplicingBase SequenceHEK293 CellsHumansMutagenesis, InsertionalRegulatory Elements, TranscriptionalRNA PrecursorsRNA SplicingRNA Splicing FactorsSerine-Arginine Splicing FactorsSMN Complex ProteinsRNA PrecursorsRNA Splicing FactorsSerine-Arginine Splicing FactorsSMN Complex ProteinsSRSF2 protein, human

Identifiers

PMID28712387
PMCPMC5595172
OpenAlexW2761692934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.